Skip to content

Independent prescribing by advanced physiotherapists for patients with low back pain in primary care: a feasibility trial with an embedded qualitative component

Independent prescribing by advanced physiotherapists for patients with low back pain in primary care: a feasibility trial with an embedded qualitative component

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15516596
Enrollment
30
Registered
2018-09-11
Start date
2018-10-01
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low back pain Musculoskeletal Diseases

Interventions

Randomisation will not occur in this feasibility trial as the aim is to test the methods etc. The feasibility trial will use the proposed experimental arm for the full study to test the feasibility of

Sponsors

University of Birmingham
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male and female patients, aged >18 years 2. Non-specific LBP +/- leg pain requiring medication advice and drug prescription on assessment 3. Classified as Moderate risk using the STarT Back Tool (classified as potentially benefiting from medicines and active physiotherapy treatment) 4. Able to read/communicate in English (due to funding restrictions for interpreters and translators limited in the inclusion of participant speaking other languages) 5. Capable of following the demands inherent of the study

Exclusion criteria

Exclusion criteria: 1. Signs of lumbar nerve root compression 2. Red Flags including potential spinal fracture, inflammatory disease, infection or malignancy 3. Spinal stenosis 4. Suspicion of or confirmed corda equine syndrome 5. Does not have capacity to consent

Design outcomes

Primary

MeasureTime frame
Measured at 6 and 12 weeks: 1. Overall pain, measured using the Numerical Rating Scale (NRS) 2. Disability, assessed using the Roland Morris Disability Questionnaire (RMDQ)

Secondary

MeasureTime frame
Measured at 6 and 12 weeks: 1. Health-related quality of life, measured using EQ5D 2. Kinesiophobia, measured using the Tampa scale 3. Physical activity/sedentary behaviour, measured using accelerometers 4. Sleep, measured using accelerometers 5. Return to work (days) 6. Prescription utilisation (number of occasions) 7. Number of appointments with other healthcare professionals about this episode of LBP

Countries

United Kingdom

Contacts

Public ContactTimothy Noblet

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 21, 2026